跳至主要内容
临床试验/NCT01330121
NCT01330121已完成不适用

Pharmacist Discharge Counseling: Bridging the Gap by Transitional Care

Cook County Health2 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2010年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
130
试验地点
2
主要终点
Adherence with discharge diabetes medications up to 120 days following pharmacist counseling during hospital stay about diabetes self management

研究概览

简要总结

The purpose of the study is to evaluate patient adherence with discharge diabetes medications up to 120 days following pharmacist counseling during hospital stay about diabetes self management

详细描述

It is a prospective, randomized, controlled Study. Patients randomized in a 1:1 ratio to pharmacist counseling or standard of therapy prior to discharge.

Standard therapy: Nurses distribute a education pamphlet on diabetes.

Pharmacist Counseling includes but is not limited to:

  • Reviewing and explaining their medications (dosing, side effects, route)
  • Reviewing symptoms and complications of hyper and hypoglycemia
  • Defining glycemic & non-glycemic goal levels
  • Explaining the importance of compliance with medications & appointments
  • Educating on the basics of nutrition and physical activity

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males or females
  • 18 to 85 years of age
  • Historical diagnosis of type 2 diabetes mellitus greater than one year
  • HbA1c concentration ≥ 8%
  • Discharged from general medicine unit of John H. Stroger Jr, Hospital of Cook County
  • Patient with provider and prescriptions filled within CCHS

排除标准

  • Type 1 diabetes mellitus
  • Pregnancy
  • Major illness or debility, that prohibits the subject from participating in the study
  • History of any hemoglobinopathy that may affect determination of HbA1c
  • Non-English speaking patients

结局指标

主要结局

Adherence with discharge diabetes medications up to 120 days following pharmacist counseling during hospital stay about diabetes self management

时间窗: up to 120 days

The primary efficacy endpoint will be the difference in rate of adherence with medications Adherence will be assessed at 30, 60, 90, and 120 days following discharge An average of the total adherence rate 120 days following discharge will be calculated as the primary outcome measure

次要结局

  • Change in lipids after 90 days(up to 90 days)
  • Change in BP after 90 days(up to 90 days)
  • Change in A1c after 90 days(up to 90 days)

研究者

发起方
Cook County Health
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Leon Fogelfeld MD

Chair, Division of Endocrinology

Cook County Health

研究点 (2)

Loading locations...

相似试验